drugset / Trial / NCT03034018
Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to determine the effect of suvorexant on insomnia symptoms in peri- and postmenopausal women who are experiencing sleep difficulties related to nighttime hot flashes.
Timeline
- Start
- 2017-05-25
- Primary completion
- 2020-04-03
- Completion
- 2020-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Suvorexant | Small molecule | 10 mg | Oral |
| Subject | Suvorexant | Small molecule | 20 mg | Oral |